PET study to determine Muscarinic receptor occupancy in lungs after inhalation of AZD2115 and Tiotropium

Trial Identifier:	D3060C00014
Sponsor:	AstraZeneca
NCTID::	NCT03097380
Start Date:	April 2017
Primary Completion Date:	December 2017
Study Completion Date:	December 2017
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Sweden	Stockholm, Sweden, 171 76

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.